# The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism

> **NCT03868657** · NA · COMPLETED · sponsor: **Signe Torekov** · enrollment: 44 (actual)

## Conditions studied

- Long QT Syndrome
- Hypoglycemia

## Interventions

- **DRUG:** Moxifloxacin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03868657
- **Lead sponsor:** Signe Torekov
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-28
- **Primary completion:** 2019-08-19
- **Final completion:** 2020-03-09
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03868657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03868657, "The Physiological Effects of Human Ether-a-go-go-Related Gene (hERG)Blockade on Metabolism". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03868657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*